Chromatin and Disease Group, Cancer Epigenetics and Biology Programme, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Mol Cancer Res. 2011 Aug;9(8):1139-51. doi: 10.1158/1541-7786.MCR-10-0515. Epub 2011 Jul 7.
Transcription factors are common targets of epigenetic inactivation in human cancer. Promoter hypermethylation and subsequent silencing of transcription factors can lead to further deregulation of their targets. In this study, we explored the potential epigenetic deregulation in cancer of Ikaros family genes, which code for essential transcription factors in cell differentiation and exhibit genetic defects in hematologic neoplasias. Unexpectedly, our analysis revealed that Ikaros undergoes very specific promoter hypermethylation in colorectal cancer, including in all the cell lines studied and around 64% of primary colorectal adenocarcinomas, with increasing proportions in advanced Duke's stages. Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing (LRES) region. Reintroduction of Ikaros in colorectal cancer cells, ChIP-chip analysis, and validation in primary samples led us to identify a number of direct targets that are possibly related with colorectal cancer progression. Our results not only provide the first evidence that LRES can have functional specific effects in cancer but also identify several deregulated Ikaros targets that may contribute to progression in colorectal adenocarcinoma.
转录因子是人类癌症中表观遗传失活的常见靶点。转录因子启动子的过度甲基化和随后的沉默会导致其靶基因的进一步失调。在这项研究中,我们探讨了 Ikaros 家族基因在癌症中的潜在表观遗传失调,该基因编码细胞分化所必需的转录因子,并在血液肿瘤中存在遗传缺陷。出乎意料的是,我们的分析表明,Ikaros 在结直肠癌中经历了非常特异性的启动子过度甲基化,包括在所研究的所有细胞系和大约 64%的原发性结直肠腺癌中,在更高级别的 Duke 分期中比例增加。Ikaros 的甲基化发生在一个新的长程表观遗传沉默(LRES)区域。在结直肠癌细胞中重新引入 Ikaros,ChIP-chip 分析,并在原发性样本中进行验证,使我们鉴定了一些可能与结直肠癌细胞进展相关的直接靶基因。我们的研究结果不仅首次证明了 LRES 可能在癌症中具有功能特异性的影响,还鉴定了一些失调的 Ikaros 靶基因,它们可能促进结直肠腺癌的进展。